Success Metrics

Clinical Success Rate
96.3%

Based on 26 completed trials

Completion Rate
96%(26/27)
Active Trials
4(11%)
Results Posted
54%(14 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_1
7
19%
Ph not_applicable
4
11%
Ph phase_2
21
58%
Ph phase_4
1
3%
Ph phase_3
3
8%

Phase Distribution

7

Early Stage

21

Mid Stage

4

Late Stage

Phase Distribution36 total trials
Phase 1Safety & dosage
7(19.4%)
Phase 2Efficacy & side effects
21(58.3%)
Phase 3Large-scale testing
3(8.3%)
Phase 4Post-market surveillance
1(2.8%)
N/ANon-phased studies
4(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.7%

26 of 29 finished

Non-Completion Rate

10.3%

3 ended early

Currently Active

4

trials recruiting

Total Trials

36

all time

Status Distribution
Active(6)
Completed(26)
Terminated(3)
Other(1)

Detailed Status

Completed26
Recruiting4
Not yet recruiting2
Withdrawn2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
36
Active
4
Success Rate
96.3%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (19.4%)
Phase 221 (58.3%)
Phase 33 (8.3%)
Phase 41 (2.8%)
N/A4 (11.1%)

Trials by Status

unknown13%
terminated13%
recruiting411%
not_yet_recruiting26%
completed2672%
withdrawn26%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT01155362Phase 2

PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Completed
NCT06481475Phase 2

A Study to Investigate the Safety and Efficacy of YY003 in Adults With Moderate to Severe Glabellar Lines

Completed
NCT07118241Phase 2

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE

Recruiting
NCT07650383Phase 1

A Study to Evaluate ENERGI-F705 Tablets in Healthy Volunteers

Completed
NCT03414645Phase 1

Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease

Completed
NCT06903611Phase 3

Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye

Not Yet Recruiting
NCT04909450Phase 1

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Completed
NCT07076784Not Applicable

Topical Icariin on Acne and Acne Scars

Completed
NCT07382427Phase 2

A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails

Not Yet Recruiting
NCT06919081Phase 2

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

Recruiting
NCT07118254Phase 2

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)

Recruiting
NCT06182358Phase 4

Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers

Completed
NCT05409235Phase 2

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Completed
NCT05629390Phase 3

Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
NCT05157958Phase 2

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Recruiting
NCT04402060Phase 1

A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19

Completed
NCT04110366Not Applicable

Nasal and Systemic Immune Responses to Nasal Influenza Vaccine

Completed
NCT04708236Phase 1

A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia

Withdrawn
NCT01020968Phase 2

Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy

Completed
NCT03229759Phase 2

Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth

Completed

Drug Details

Intervention Type
DRUG
Total Trials
36